CURRENT PATTERNS OF FIXED AND FREE LABA/ICS COMBINATION USAGE IN ASTHMA SHI PATIENTS IN GERMANY

被引：0
|
作者：
Bonthapally, V [1 ]
Wolbring, F. [2 ]
Sindern, J. [2 ]
Mehnert, A. [2 ]
机构：
[1] Univ Louisiana, Monroe, LA USA
[2] Janssen Cilag GmbH, Neuss, NRW, Germany
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A128 / A128
页数：1
相关论文
共 50 条
  • [21] ADD-ON EFFECT OF TIOTROPIUM BROMIDE TO ICS/LABA COMBINATION INHALER FOR PERIPHERAL AIRWAYS AMONG PATIENTS WITH SEVERE UNCONTROLLED ASTHMA
    Hojo, M.
    Iikura, M.
    Suzuki, M.
    Sugiyama, H.
    RESPIROLOGY, 2014, 19 : 4 - 4
  • [22] Burden of asthma among patients adherent to ICS/LABA: A real-world study
    Davis, Jill
    Trudo, Frank
    Siddall, James
    Small, Mark
    JOURNAL OF ASTHMA, 2019, 56 (03) : 332 - 340
  • [23] The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
    Czira, Alexandrosz
    Martin, Amber
    Turner, Monica
    Meeraus, Wilhelmine
    Birch, Helen
    Zhang, Shiyuan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] Six Months Step Down Treatment From High Dose ICS/LABA Combination Therapy In Asthma
    Paggiaro, P.
    Nicolini, G.
    Crimi, N.
    Fabbri, L.
    Olivieri, D.
    Rossi, A.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [25] The MiSTIC Study Design: Medium Strength Triple Therapy Vs High Strength ICS/LABA for Adult Patients With Asthma Uncontrolled on Medium Strength ICS/LABA
    Kostikas, K.
    Topole, E.
    Singh, D.
    Brusselle, G. G.
    Kots, M.
    Vele, A.
    Georges, G.
    Papi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] Effects Of Roflumilast In COPD Patients Receiving Ics/laba Fixed-Dose Combination: Rationale And Design Of A Prospective Randomized Controlled Trial
    Rennard, S. I.
    Martinez, F. J.
    Sethi, S.
    Zhu, H.
    Haberman, R.
    Zovko, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [27] "it Must Be Doing Something": COPD Patients' Rationales For Using Combination Ics/laba Treatment
    Foster, J. M.
    Jenkins, C. R.
    Toelle, B. G.
    Smith, L.
    Reddel, H. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [28] Asthma Symptoms And Health Care Resource Utilization By Degree Of Asthma Control In Patients Adherent To Ics/laba Treatment
    Davis, J.
    Trudo, F.
    Siddall, J.
    Bostock, T.
    Small, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI)
    Al-Ahmad, Mona
    Webb, David
    RESPIRATORY MEDICINE, 2022, 194
  • [30] Efficacy and Safety of a Fixed Combination Extrafine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI Treatment Compared to Fixed Combination BDP/FF in Patients with Uncontrolled Asthma on Medium Dose ICS/LABA: The TRIMARAN Study
    Paggiaro, P.
    Kuna, P.
    Kots, M.
    Corre, S.
    Carzana, E.
    Vele, A.
    Georges, G.
    Petruzzelli, S.
    Virchow, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345